Child cancer and birth defects: hidden genetic clues?
NCT ID NCT01915797
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This completed study collected information from nearly 1,000 children who had both cancer and developmental abnormalities like birth defects or growth issues. The goal was to find new genetic syndromes that make children more likely to develop cancer. Researchers analyzed blood and tumor samples to understand the underlying causes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help identify new genetic syndromes that make children more likely to develop cancer, leading to earlier detection and better monitoring.
- What could go wrong
- This is an observational study, not a treatment trial. It may not directly benefit participants, and identifying new syndromes does not guarantee improved outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALIGNANT HEMOPATHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hôpital Necker Enfants Malades
Paris, 75015, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Taste and smell tests for kids with cancer: a feasibility study
- AI and big data join the fight against childhood brain cancer relapse
- Can tumor profiling help kids beat cancer? new study aims to find out
- New radioactive drug targets childhood cancers that Won't quit
- New cocktail of four drugs aims to tackle childhood cancers that Won't go away
- Lockdown diaries: 1,300 patients reveal hidden health risks